Dia-Beta Labs vs Epocrates
Dia-Beta Labs vs Epocrates, compared side by side on 10 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Dia-Beta Labs is on 34/100 and Epocrates on 69/100.
Where each one leads
Dia-Beta Labs
Leads on none of the measures we hold for both companies.
Epocrates
- our overall score: 69/100 against 34/100
- funding raised: $175M against $3.0M
At a glance
| Measure | Dia-Beta Labs | Epocrates |
|---|---|---|
| What it is | Dia-Beta Labs is a startup focused on developing innovative solutions for diabetes management. | A widely used mobile medical reference application for healthcare professionals. |
| Category | HealthTech, MedTech, Diabetes Management, Digital Health | HealthTech, MedTech, Clinical Decision Support, Mobile Health |
| Sells toBusiness model | B2C | B2B |
| Offering | Software | Software |
| Founded | Not published | 1998 |
| Headquarters | San Francisco, United States | San Mateo, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Dia-Beta Labs | Epocrates |
|---|---|---|
| Total funding | $3.0M | $175M |
| Latest round | Seed | Acquisition |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Dia-Beta Labs | Epocrates |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 69/100 |
| Traction | 32/100 | 17/100 |
| Quality | 48/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (38/100) |
| Domain ratingLink authority, 0-100 | Not published | 71/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Dia-Beta Labs | Epocrates |
|---|---|---|
| Hosting | Not detected | AWS |
Dia-Beta Labs vs Epocrates: common questions
Which is better, Dia-Beta Labs or Epocrates?
On our 0-100 score Epocrates rates higher (69/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 10 data points above: read the rows that match what you are buying for.
How do Dia-Beta Labs and Epocrates compare on the numbers?
Epocrates leads on our overall score (69/100 against 34/100), funding raised ($175M against $3.0M).
Read the full Dia-Beta Labs review and pricing or the Epocrates review and pricing. You can also browse other Dia-Beta Labs alternatives we track.